Streetbeat News

Stock Prices

CRSP

CRISPR Therapeutics (CRSP) has experienced a prolonged decline in its stock price over the past three years. However, recent positive news could signal a potential buying opportunity for investors.

Portfolio Pulse from

December 22, 2024 | 5:45 pm

TMC

Pomerantz Law Firm has filed a class action lawsuit against TMC the metals company Inc. and certain officers, alleging violations of federal securities laws. The lawsuit seeks damages for investors who acquired TMC securities between May 12, 2023, and March 25, 2024.

Portfolio Pulse from

December 22, 2024 | 5:30 pm

KYTX

Kyverna Therapeutics, Inc. is facing a lawsuit for alleged securities law violations. Investors who have suffered losses are encouraged to contact Levi & Korsinsky for potential recovery options.

Portfolio Pulse from

December 22, 2024 | 5:30 pm

SYM

Symbotic Inc. is facing a lawsuit for alleged securities law violations. Investors who have suffered losses are encouraged to contact Levi & Korsinsky for potential recovery options.

Portfolio Pulse from

December 22, 2024 | 5:30 pm

BA

Boeing has announced a significant order for its 737 MAX from Pegasus Airlines, signaling confidence in the aircraft and Boeing's delivery capabilities. This development is expected to have a bullish impact on Boeing's stock in 2025.

Portfolio Pulse from

December 22, 2024 | 5:30 pm

NVDA

Nvidia has been a dominant force in the AI stock market, with a significant rise in value over the past five years. However, the article suggests there is another AI stock, down 44%, that presents a strong buying opportunity.

Portfolio Pulse from

December 22, 2024 | 5:30 pm

MYNA

Pomerantz Law Firm has filed a class action lawsuit against Mynaric AG (NASDAQ:MYNA) and certain officers, alleging violations of federal securities laws. The lawsuit is for investors who acquired Mynaric securities between June 20, 2024, and October 7, 2024.

Portfolio Pulse from

December 22, 2024 | 5:30 pm

KYTX

Pomerantz Law Firm has filed a class action lawsuit against Kyverna Therapeutics, Inc. (NASDAQ:KYTX) and reminds shareholders with losses to take note of upcoming deadlines.

Portfolio Pulse from

December 22, 2024 | 5:30 pm

PACS

Levi & Korsinsky is inviting shareholders of PACS Group, Inc. to discuss potential recovery options under federal securities laws if they have suffered losses. Shareholders should contact the firm before January 13, 2025.

Portfolio Pulse from

December 22, 2024 | 5:30 pm